Filter News
Area of Research
- (-) Fusion and Fission (4)
- (-) Neutron Science (8)
- Biology and Environment (10)
- Clean Energy (12)
- Computational Engineering (1)
- Fusion Energy (1)
- Isotope Development and Production (1)
- Isotopes (2)
- Materials (7)
- Materials for Computing (2)
- National Security (6)
- Nuclear Science and Technology (5)
- Sensors and Controls (1)
- Supercomputing (22)
News Topics
- (-) Advanced Reactors (3)
- (-) Biomedical (4)
- (-) Coronavirus (5)
- (-) Frontier (1)
- (-) Security (1)
- (-) Space Exploration (1)
- 3-D Printing/Advanced Manufacturing (3)
- Artificial Intelligence (1)
- Big Data (1)
- Bioenergy (3)
- Biology (4)
- Biotechnology (1)
- Chemical Sciences (1)
- Climate Change (1)
- Composites (1)
- Computer Science (6)
- Cybersecurity (1)
- Decarbonization (2)
- Energy Storage (3)
- Environment (3)
- Fossil Energy (1)
- Fusion (8)
- Grid (1)
- High-Performance Computing (1)
- ITER (2)
- Materials (6)
- Materials Science (14)
- Microscopy (2)
- Nanotechnology (7)
- National Security (1)
- Neutron Science (40)
- Nuclear Energy (10)
- Partnerships (2)
- Physics (7)
- Quantum Science (4)
- Simulation (1)
- Summit (4)
- Sustainable Energy (3)
- Transportation (3)
Media Contacts
Mickey Wade has been named associate laboratory director for the Fusion and Fission Energy and Science Directorate at the Department of Energy’s Oak Ridge National Laboratory, effective April 1.
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.
Paul Langan will join ORNL in the spring as associate laboratory director for the Biological and Environmental Systems Science Directorate.
ORNL and the Tennessee Valley Authority, or TVA, are joining forces to advance decarbonization technologies from discovery through deployment through a new memorandum of understanding, or MOU.
More than 50 current employees and recent retirees from ORNL received Department of Energy Secretary’s Honor Awards from Secretary Jennifer Granholm in January as part of project teams spanning the national laboratory system. The annual awards recognized 21 teams and three individuals for service and contributions to DOE’s mission and to the benefit of the nation.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
David Kropaczek, director of the Consortium for Advanced Simulation of Light Water Reactors, or CASL, at the Department of Energy’s Oak Ridge National Laboratory, has been named a fellow of the American Nuclear Society.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
A team of researchers has performed the first room-temperature X-ray measurements on the SARS-CoV-2 main protease — the enzyme that enables the virus to reproduce.